Found 8 matching trials
Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma NA RATIONALE: Diagnostic procedures that analyze surgically-removed tumor tiss...
Show More Location
University of Chicago Cancer Research Center
Learn More & Join Trial
Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients N/A In this large-scale cross-sectional study, we evaluated disease-free surviv...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer PHASE3 RATIONALE: Studying the proteins expressed in samples of blood and tissue f...
Show More Location
Istituto Scientifico H. San Raffaele
Learn More & Join Trial
Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients NA The anaplastic lymphoma kinase gene(ALK) is mutated approximately 5% of non...
Show More Location
BC Cancer Agency-Abbotsford Centre
Learn More & Join Trial
Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women) PHASE2 RATIONALE: Drugs used in chemotherapy, such as paclitaxel, cyclophosphamide...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute, University of South Florida
Learn More & Join Trial
Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers N/A GENCONCOR-2 is a translational research aimed to compare the molecular prof...
Show More Location
Blokhin's Russian Cancer Research Center
Learn More & Join Trial
Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer PHASE2 RATIONALE: Studying samples of tumor tissue from patients with cancer in th...
Show More Location
Leeds Cancer Centre at St. James's University Hospital
Learn More & Join Trial
Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery PHASE2 RATIONALE: Monoclonal antibodies, such as cetuximab, can block tumor growth...
Show More Location
Universitair Ziekenhuis Antwerpen
Learn More & Join Trial